how expensive is glp-1 Antagonists Increase Plan Drug Spend - What's Next I thought hers GLP-1 was

Jones KL, Rigda RS, Buttfield MDM, Hatzinikolas S, Pham HT, Marathe CS, et al

A: According to ro.co , eligibility requirements include: Age 18+ (some services may require 21+) Resident of state where Ro operates weight loss services BMI 30 (obesity) OR BMI 27 (overweight) with at least one weight-related condition No personal or family history of medullary thyroid carcinoma (MTC) No Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Not pregnant, planning pregnancy within 2 months, or breastfeeding No contraindications for GLP-1 medications Provider approval required based on comprehensive medical evaluation Meeting basic eligibility doesn't guarantee medication approval

Perley and D.M

According to NICE guidance (NG28), the continuation of GLP-1 receptor agonist therapy in type 2 diabetes should be assessed after six months, with treatment continued only if there is a reduction in HbA1c of at least 11 mmol/mol (1%) and, where applicable, a weight loss of at least 3% of initial body weight

The Great (Oral) GLP-1 Scare Why the Stevanato narrative is flawed This is not something that should take you by surprise because Ive talked about it in the past, but Stevanatos stock has been weak lately (maybe an understatement): This has happened despite the company (imho) receiving incrementally positive news over the past few months

Back Tu, L (16 Oct 2023) 'Should insurance cover Wegovy, Ozempic and other weight-loss drugs?', Scientific American